Long-term outcomes of endoscopic treatment of aberrant hepatic duct injuries after cholecystectomy
Gastrointestinal Endoscopy Dec 05, 2019
Tringali A, Massinha P, Schepis T, et al. - In this retrospective analysis, researchers examined the long-term outcomes of endoscopic treatment of aberrant hepatic duct lesions after cholecystectomy. Study participants included patients who had ERCP for aberrant hepatic duct lesions. Thirty-two patients (mean age 51.7 years) with aberrant hepatic duct injuries had ERCP at the Endoscopy Unit between January 1996 and March 2019. Data reported that six patients had Strasberg type B lesions, 11 patients had type C, and 8 patients had type E5, and 7 patients had a stenosis of the aberrant duct. An effective first-line therapy can be considered as an endoscopic approach to aberrant hepatic duct lesions after cholecystectomy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries